Honeywell HomMed and eDevice said that the new bundle will further increase the benefits of telehealth monitoring for patients and healthcare providers by offering greater access to health information utilising existing network coverage at the patient’s location. It is designed for use at a patient’s home for continuous health monitoring, it provides greater access to health information, enhancing efficiency and improving patient outcomes.
The Genesis DM telehealth device measures vital signs such as heart rate, blood pressure, weight, and SPo2, and provides customisable subjective disease-related queries for a more complete picture of an individual’s health. Automated and secure transfer of medical and vital signs records is made using eDevice eHealth data communication terminals and modules.
Terry Duesterhoeft, president of Honeywell HomMed, said: “International eDevice multi-network services and products provide a unique end-to-end solution for national and worldwide eHealth roll-out projects. Thanks to eDevice solutions, Honeywell HomMed offers one of the broadest ranges of connectivity options in the telehealth industry, which allows care providers to simplify their roll-out while reducing costs and improving the patient’s experience.”
Marc Berrebi, CEO of eDevice, said: “Such innovative homecare systems are part of the solution for improving quality of care for aging populations. In the future policy makers shall certainly take into consideration the financial benefits resulting from innovative mHealth solutions.”
Honeywell HomMed is a part of the Honeywell Automation and Control Solutions business group, a provider in providing product and service solutions that improve efficiency and profitability, support regulatory compliance, and maintain safe, comfortable environments in homes, buildings and industry.
